Published August 24, 2022 | Version v1
Poster Open

A study protocol for AI-Mind: Artificial intelligence combined with neurophysiological and neuropsychological measures for dementia prediction

Authors/Creators

  • 1. BioMag Laboratory, HUS Diagnostic Center, Helsinki University Hospital, Finland
  • 2. Department of Clinical Neurosciences/ Neurology, Helsinki University Hospital

Description

Over 10 million Europeans suffer from mild cognitive impairment (MCI), a condition between expected aging and dementia. While many MCI patients remain stable, ~50% of them progress to dementia within five years. In these subjects, the first neurodegenerative changes occur years before clinical symptoms. Early pathology, causing brain network disturbances, could potentially be observed with advanced electroencephalography (EEG) and magnetoencephalography (MEG) analysis. Yet, EEG/MEG signals are currently not widely utilized in dementia risk assessment.

The poster presents the study protocol of AI-Mind project, which aims to enrol 1'000 participants with MCI in five clinical centres in Europe. 

Files

Kuopio_HUS_poster_AIMind_2022-08-24.pdf

Files (951.6 kB)

Name Size Download all
md5:ba6e1677396706f01f2b09410b0b9a29
951.6 kB Preview Download

Additional details

Funding

European Commission
AI-Mind - Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment. 964220